U.S. market Closed. Opens in 22 hours 22 minutes

SNTI | Senti Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue2.56M4.29M2.29M394.00K85.00K
Cost of Revenue5.24M3.92M3.01M15.96M14.52M
Gross Profit-2.68M366.00K-719.00K-15.56M-14.44M
Operating Expenses95.29M74.92M42.74M25.09M7.39M
Selling, General & Admin34.87M40.85M21.25M9.30M7.34M
Research & Development32.15M34.07M21.96M15.96M14.52M
Other Operating Expenses27.69M12.42M-470.00K-172.00KN/A
Operating Income-92.73M-70.63M-40.45M-24.69M-21.78M
Other Expenses / Income9.32M12.42M-14.87M4.83M625.00K
Before Tax Income-83.41M-58.21M-55.32M-19.86M-21.16M
Income Tax ExpensesN/A-12.42M11.00K150.00KN/A
Net Income-92.92M-58.21M-55.32M-19.86M-21.16M
Interest ExpensesN/AN/AN/AN/AN/A
Basic Shares Outstanding4.44M2.61M4.37M4.37M13.59M
Diluted Shares Outstanding4.44M2.61M4.37M4.37M13.59M
EBITDA-61.34M-70.63M-39.68M-22.71M-21.36M
EBITDA Margin-2,395.00%-1,647.90%-1,731.86%-5,763.71%-25,123.53%
EBIT-92.92M-70.63M-55.31M-19.71M-21.16M
EBIT Margin-3,628.23%-1,647.90%-2,414.14%-5,003.05%-24,890.59%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙